Amlodipine/Candesartan/Indapamide (Shin Poong Pharmaceutical)

氨氯地平/坎地沙坦西酯/吲达帕胺 (韩国新丰制药株式会社)

Report date: 2025/02/21 10:54:40

Base Information

Drug NameAmlodipine/Candesartan/Indapamide (Shin Poong Pharmaceutical)
Drug Alias NameSPC1001SPC-1001SPC-3001SPC-4001SPC-4002 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersSymporters inhibitors
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channelSymporters
Therapy Area/IndicationsDiabetes MellitusEssential HypertensionHypertension +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes AmlodipineCandesartan CilexetilIndapamide
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesShin Poong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShin Poong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusEssential HypertensionHypertension +[4] 
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A